Amylin, Takeda discontinue development of obesity drug
SAN DIEGO — Amylin Pharmaceuticals and Takeda Pharmaceutical have halted development of a treatment for obesity in mid-stage clinical trials, the two companies said.
The companies said the decision to discontinue development of a therapy that combines pramlintide and metreleptin was based on "a commercial reassessment of the pramlintide/metreleptin program … [that] took into account a revised development plan, as well as evolving dynamics within he obesity therapeutic area."
Nevertheless, the companies said they would continue investigating other treatments for obesity.
NACDS praises introduction of legislation to curb organized theft of medical products
ALEXANDRIA, Va. — A bipartisan bill that aims to provide law enforcement with tools to crack crime rings that harm consumers by attempting to resell stolen medical products on the black market has received the praise of the National Association of Chain Drug Stores.
In a letter sent to Sen. Charles E. Schumer, D-N.Y., NACDS thanked him for his leadership in introducing and advancing S. 1002, the “Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2011,” also called the “SAFE DOSES Act.”
The letter cites the importance of the bill in the fight against the organized theft of medical products, specifically prescription drugs, biologicals, devices and infant formula.
“Your timely legislation comes amid concerns that criminal organizations are increasingly targeting prescription drugs and other medical products, and particularly goods in transit, because of the high value of shipments. It would combat this type of theft by increasing penalties, stiffening sentences for these crimes, making theft of medical products a predicate for the Racketeer Influenced and Corrupt Organizations law, as well as providing law enforcement officials with additional mechanisms to fight dangerous crime rings,” NACDS stated in its letter.
“We commend you again for introducing and advancing strong bipartisan legislation that will assist healthcare providers, retailers and law enforcement combat the serious problem of organized theft of medical products and we look forward to working with you to enact this important legislation,” the letter concluded.
Delhaize America turns out positive Q2 results
SALISBURY, N.C. — New stores, higher retail inflation and positive calendar impact drove sales up for Delhaize America, the U.S. sector of the Delhaize Group, during the second quarter ended June 30.
The division, which operates such banners as Food Lion, Hannaford and Bottom Dollar Food, reported that revenues rose 4.3% to $4.9 billion, while comparable-store sales increased 1.6%. Operating profit, however, dropped 2.7% to $205 million.
The results are very encouraging, Delhaize Group president and CEO Pierre-Oliver Beckers said, as the supermarket conglomerate has put a great emphasis on its U.S. business with the relaunch of about 200 Food Lion stores in the Raleigh, N.C., and Chattanooga, Tenn., markets, in addition to the expansion of the Bottom Dollar Food banner, which is adding more stores in the greater Philadelphia market and also will break ground in the greater Pittsburgh and Youngstown, Ohio, markets, with 14 stores expected to open early next year.
At the end of June 2011, Delhaize Group operated 1,638 supermarkets in the United States.